Home » Newsletters » BioWorld Asia

BioWorld Asia

July 26, 2000

View Archived Issues

Bone Marrow Could Yield Cells To Repopulate All Cell Types

French Start-Up Innate Pharma Raises $4.5M For Cancer Work

Compugen Plans IPO On Nasdaq Following $35M Private Financing

Ardana Spins Out OF MRC To Focus On Women's Health

EuropaBio, EPPOSI Meeting Focused On Rare Diseases

Vernalis' Migraine Treatment Cleared For French Market

EU Minister Remain Cautious About GMO Authorizations

G8 Leaders Take Supportive Stance On Biotechnology

Personal Chemistry Seeks $20M After Patent Questions Sink IPO

GPC, Cytovia Collaborate On Reverse Genomics, Cell Assays

Teva Strengthens European Ties With $135M Financing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...